Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan · Delayed Price · Currency is JOD 1.550
-0.040 (-2.52%)
At close: Mar 18, 2026
ASE:PHIL Revenue
In the year 2025, Philadelphia Pharmaceuticals Company had annual revenue of 9.17M JOD with 4.64% growth. Philadelphia Pharmaceuticals Company had revenue of 2.31M in the quarter ending December 31, 2025, with 2.51% growth.
Revenue
9.17M
Revenue Growth
+4.64%
P/S Ratio
1.27
Revenue / Employee
71.08K
Employees
129
Market Cap
11.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.17M | 406.53K | 4.64% |
| Dec 31, 2024 | 8.76M | 357.51K | 4.25% |
| Dec 31, 2023 | 8.40M | -10.46K | -0.12% |
| Dec 31, 2022 | 8.42M | 1.81M | 27.48% |
| Dec 31, 2021 | 6.60M | -1.05M | -13.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition